Michael J Fox Foundation announces 2017 highlights

News

Author: Parkinson's Life editorsPublished: 4 January 2018

Prep: Cook: Serves:

The Michael J Fox Foundation has announced that it provided US$80 million in funding to over 240 investigators from academia, biotechnology, pharmaceuticals and governments in 2017.

The organisation, which was founded in 2000 by the actor and person with Parkinson’s Michael J Fox, has funded a range of projects, focusing on: investigating Parkinson’s biological pathways, laboratory tools to accelerate Parkinson’s research, and growing the online Fox Insight study.

The foundation also shared the significant research progress that was made in 2017, such as the advancement of alpha-synuclien clinical trials, the release of new drugs to manage motor symptoms and the emergence of key technologies that provide insights to scientists.

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Save the last dance for Google Glass

How innovative software is helping patients dance off symptoms

Parkinson’s in Barbados is “overshadowed by other conditions”

We talk to the founder of Barbados’ only Parkinson’s support group

Can a diabetes drug be repurposed to treat Parkinson’s too?

Common diabetes drug may have potential to treat Parkinson’s

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

A new screening tool has been developed to support the early diagnosis of Parkinson’s disease psychosis – a symptom of the condition that is often misdiagnosed. Created by Canadian senior care software company, PointClickCare and membership organisation, the American Society of Consultant Pharmacists (ASCP), the platform asks questions on topics like hallucinations and delusions. Healthcare workers can then review the responses and decide to collect more information and create a care plan. Data collected through the tool will also be used to help scientific research in healthcare organisations. Bill Stuart, clinical product strategist at PointClickCare said: “Not only will the screener tool better enable faster diagnosis, it will provide the senior care industry with a consistent way of approaching Parkinson’s psychosis.” Chad Worz, chief executive of ASCP, added: “We are excited to have another tool for care teams to facilitate a more standardised care process for Parkinson’s disease and we…

Has Covid-19 impacted access to Parkinson’s medication?

New research has found that the coronavirus pandemic has affected access to medication for people living with Parkinson’s disease. The sub-study used information from a survey conducted by the International Parkinson and Movement Disorder Society. The results from 346 participants showed that 22.8% of high-income and 88.9% of low-income countries’ respondents agreed that the coronavirus crisis had impacted people’s access to Parkinson’s medication. Some respondents reported increased disability, increased hospitalisation and increased mortality as factors. The majority of those who completed the survey were doctors. The researchers concluded: “Our results offer preliminary data that the Covid-19 pandemic has affected Parkinson’s disease patients’ access to regular medication. “Covid-19 has diverted resources away from chronic conditions towards the fight against Covid-19 in many countries. Resource-poor countries seem to be disproportionately affected compared to their affluent counterparts.”

Brazilian dance could improve mobility in people with Parkinson’s, study finds

Researchers at the Federal University of Rio Grande do Sul in Brazil compared participants in a 12-week programme, inspired by samba and forró dances, with those in a walking exercise programme to measure improvement in their functional mobility and gait. The 18 participants had an average age of 68.6 and had all been diagnosed with Parkinson’s over a year ago. The results, published in journal BMC Neurology, found that both groups showed significant improvements in mobility and balance tests. Participants in the dance group showed increases in stride frequency at a self-chosen test speed and a reduced swing time (the amount of time the foot is off the floor) at a fast speed. The results indicated that dance was as “effective as walking in improving functional mobility”. The researchers wrote: “It is essential to find different activities that can offer benefits to individuals… so that they can engage in the…

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Michael J Fox Foundation announces 2017 highlights

News

Author: Parkinson's Life editorsPublished: 4 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Save the last dance for Google Glass

In my country

Parkinson’s in Barbados is “overshadowed by other conditions”

Advances

Can a diabetes drug be repurposed to treat Parkinson’s too?

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

Michael J Fox Foundation announces 2017 highlights

News

Author: Parkinson's Life editorsPublished: 4 January 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Save the last dance for Google Glass

In my country

Parkinson’s in Barbados is “overshadowed by other conditions”

Advances

Can a diabetes drug be repurposed to treat Parkinson’s too?

New tool could support “faster diagnosis” of Parkinson’s disease psychosis

Has Covid-19 impacted access to Parkinson’s medication?

Brazilian dance could improve mobility in people with Parkinson’s, study finds

{title}

Subscribe

Sign in